Bioprocess Validation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Bioprocess Validation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : December, 2019 | Pharmaceutical | PPT format

Report Digest


Global Bioprocess Validation Market: Overview

Rigorous safety and quality laws thatcontrol the entire process of product certification and testing acrosspharmaceutical and biopharmaceutical industries are prognosticated to spell growth forglobal bioprocess validation market over the timeframe of stipulation.

In addition to that, numerous regulatory mandates in the healthcare sector, coupled with increasing trend of outsourcing the services of bioprocess validation, are expected to stimulate growth for the global bioprocess validation market. Services in the healthcare sector need to be in line with Good Manufacturing Practices (GMPs), which is setting the standard for the healthcare industry, thereby driving the market growth.

Global bioprocess validation market is segmented on the basis of test type, process component, end-user, and region.

Global Bioprocess Validation Market: Notable Developments

The below-mentioned strategic moves in the global bioprocess validationmarket reveal the key aspects of the dynamic:

  • In 2018, Meissner Filtration Products made an announcement that it has completed the process of acquisition of PDC Aseptic Filling Systems. The latter suppliessealers and advanced aseptic filling systems to the pharmaceutical sector. Following the acquisition, it is expected that the products of PDC Aseptic Filling Systems would complement Meissner’spresent portfolio of process solutions. These comprise unit processing offerings, single-use systems fluid handling, and filtration.
  • In 2019, Thermo Fisher Scientific Inc., a leading developer of biotechnology product, and Brammer Bio, famed maker of viral vectorfor cell and gene therapies, entered into a definitive agreement. Honoring the agreement, Thermo Fisher made an acquisition ofBrammer Bio.

Some of the most prominent competitors operating in the competitive landscape of global bioprocess validation market include –

  • Filtration Products Inc.
  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Cobetter Filtration Equipments Co., Ltd.
  • Eurofins Scientific

Global Bioprocess Validation Market: Growth Drivers

Stringent Safety Measures for Product Certification Accelerates Growth

Global bioprocess validation market is expected to be fuelled by the strict quality and safety rules that govern product testing and certification process across the pharmaceutical and biopharmaceutical sectors. The World Health Organization (WHO) asserts that quality management in the drug industry is an essential element, and validation is an essential part of GMP. According to the WHO, licensed pharmaceutical products must always be made strictly by the licensed manufacturers only. The agencyfurther mandates that the activities of those manufacturers need to be regularly scrutinized from time to time by competent nationalauthorities.

Furthermore, increased expenditure on research and development activities in the area of life sciences together with the rising demand for outsourcing the services of bioprocess validation are likely to propel the global bioprocess validation market towards growth.

Global Bioprocess Validation Market: Regional Outlook

Considering geographies of the global bioprocess validation market, North America is likely to hold lion’s share throughout the assessment period of 2018 – 2028. Europe is likely to trail North America in the coming years.

The North America bioprocess validation market is likely to gain traction fromthe concentration of a large number of key service providers of bioprocess validation in the region. In addition to that, strict regulations pertaining to the production of biopharmaceutical products are adding impetus to the demand for bioprocess validation systems in the region.

Asia Pacific is expected to emerge as a rapidly expanding region in the global bioprocess validation market during the period of assessment. This can be attributed primarily to the expanding capacities of numerous biopharmaceutical manufacturers and increased spending on research and development activities in life sciencesin the region.

The global bioprocess validation market is segmented as:

Test Type

  • Extractables and Leachables
  • Integrity Testing
  • Microbiology Testing

Process Component

  • Filter Element
  • Bioreactors

End-User

  • CDMO
  • Biotechnology Companies
  • Pharmaceutical Companies

The study presents reliable qualitative and quantitative insights into:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand chain of the market
  • Market valuation (revenue and/or volume)
  • Key trends/opportunities/challenges
  • Forces defining present and estimated future state of the competitive landscape
  • Technological developments
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.

Highlights of the report:

  • A detailed analysis of key segments of the market
  • Recent developments in the market’s competitive landscape
  • Detailed analysis of market segments up to second or third level of segmentation
  • Historical, current, and projected future valuation of the market in terms of revenue and/or volume
  • Key business strategies adopted by influential market vendors
  • Outline of the regulatory framework surrounding and governing numerous aspects of the market
  • Growth opportunities in emerging and established markets
  • Recommendations to market players to stay ahead of the competition

Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC